Literature DB >> 512411

Appearance of "pemphigus acantholysis factor" in human skin cultured with pemphigus antibody.

J R Schiltz, B Michel, R Papay.   

Abstract

These studies deal with the mechanism of pemphigus IgG-induced epidermal acantholysis. When normal human skin was culted with defined medium containing IgG from pemphigus serum, extensive epidermal acantholysis developed and heat-labile proteolytic enzyme(s) were recovered in the culture medium. The enzyme(s) displayed maximal activity at pH 6.5 when a 3H-amino acid-labeled, insoluble epidermal cell material was used as substrate. The enzyme activity increased during the first 3 days of culture and the appearance of maximal activity coincided with the time of onset of acantholysis. Acantholysis did not occur in control cultures incubated with normal IgG and the enzyme did not appear in the medium or in aqueous extracts of cultured tissues. The enzyme(s) is probably not of lysosomal origin because low pH-active proteases characteristic of these organelles remained within the cells. The effects of puromycin on appearance of enzyme activity, acantholysis and cell viability was studied. At cytotoxic concentrations, the appearance of the enzyme(s) and acantholysis were prevented, whereas at less toxic concentrations enzyme activity and acantholysis were not prevented. Because inhibition of protein synthetic rates by puromycin could not be dissociated from the cytotoxic effects, it is uncertain whether enzyme appearance and acantholysis were dependent upon living tissue or on specific protein synthesis. After pemphigus IgG was removed from the conditioned medium by DEAE cellulose and affinity column chromatography, the remaining material contained enzyme activity and caused acantholysis in fresh skin explants. Similar activities were not present in normal IgG-containing conditioned medium or unfractionated epidermal extracts from normal skin. These data indicate that when the pemphigus IgG autoantibody interacts with epidermal cell surface antigens, the cell responds by synthesis or activation of a non-IgG "pemphigus acantholysis factor" (PAF) which may be a nonlysosomal proteolytic enzyme. It is suggested that PAF causes loss of adhesion between keratinocytes and ultimately produces the characteristic acantholytic cells of pemphigus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512411     DOI: 10.1111/1523-1747.ep12541618

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Characterization of keratocalmin, a calmodulin-binding protein from human epidermis.

Authors:  J A Fairley; G A Scott; K D Jensen; L A Goldsmith; L A Diaz
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Pemphigus vulgaris and plasma exchange. Role of intercellular antibodies.

Authors:  D W Johnson; T L Simon; W G Chapman
Journal:  West J Med       Date:  1983-11

Review 4.  Antibody-induced proteinase activation: a proposed mechanism for pemphigus.

Authors:  K H Singer; K Hashimoto; G S Lazarus
Journal:  Springer Semin Immunopathol       Date:  1981-06

Review 5.  Immunologically mediated epidermal cell injury.

Authors:  R D Sontheimer; J N Gilliam
Journal:  Springer Semin Immunopathol       Date:  1981-06

6.  Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes.

Authors:  J R Stanley; M Yaar; P Hawley-Nelson; S I Katz
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.

Authors:  M Ståhle-Bäckdahl; M Inoue; G J Guidice; W C Parks
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study.

Authors:  H Dobrev; L Popova; D Vlashev
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

9.  Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.

Authors:  J R Stanley; L Koulu; C Thivolet
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Experimental human cell and tissue models of pemphigus.

Authors:  Gerda van der Wier; Hendri H Pas; Marcel F Jonkman
Journal:  Dermatol Res Pract       Date:  2010-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.